As required by regulations, UKCA marking is mandatory to put medical devices and in vitro diagnostic medical devices on the market in Great Britain. LNE-GMED UK is a subsidiary of GMED bringing you all the knowledge, experience and services of its group. LNE-GMED UK, as a UK Approved Body, can support you because of its certification process and expertise in the medical device industry.
Designated to act as a UK Approved Body under the Medical Device Regulations 2002 for medical devices, LNE-GMED UK certifies a vast range of products.
From January 1st, 2021, UKCA marking was introduced to eventually replace the CE mark in Great Britain (England, Wales, and Scotland). The CE mark will remain acceptable for a transition period which will vary depending on whether your product is a medical device or in vitro diagnostic medical device and also on risk classification.
The full scope of LNE-GMED UK is available on the UK Market Conformity Assessment Bodies (UKMCAB).
- Planning and preparation for assessment activities
- Assessment activities completion, including any special procedures needed
- Interim report issuance to the company
- Action plan submission by the company, if needed
- Action plan analysis
- Report finalisation and communication to the company
- Surveillance activities, such as audits or technical document sampling
- Control activities, such as ‘for cause’ unannounced visits or vigilance follow ups
6 Key elements
As required by medical device regulations, products that may be placed on the market or put into service must first meet applicable regulatory requirements to ensure that they are acceptably safe to use and suitable for their intended purpose.
The manufacturer must demonstrate that its device conforms to each safety and performance requirements set out in the applicable regulatory texts and submit evidence demonstrating conformity.
Before applying for certification, the manufacturer must identify the class of its medical device to determine which requirements apply. The device class is determined using classification rules laid out in the Medical Device Regulations 2002, which in turn refers to classification rules established under the Medical Device Directive (93/42/EEC), the Active Implantables Medical Device Directive (90/385/EEC) and the In Vitro Diagnostic Device Directive (98/79/EC). Any subsequent guidance that was issued to support the interpretation of such directives is applied to the implementation of the UKCA requirements.
Classification is determined based on the device’s intended use, characteristics and inherent risks.
Identifying the device class helps the manufacturer determine which conformity assessment procedure should apply. In other words, it helps the manufacturer determine which route to take to meet applicable requirements and demonstrate conformity with the applicable regulation.
The manufacturer must choose and implement a conformity assessment procedure in order to demonstrate the conformity of its products before placing them on the market or putting them into service. These conformity assessment procedures are specified in the Medical Device Regulations 2002, which in turn refers to the Medical Device Directive (93/42/EEC), the Active Implantables Medical Device Directive (90/385/EEC) and the In Vitro Diagnostic Device Directive (98/79/EC). Any subsequent guidance that was issued to support the interpretation of such directives is applied to the implementation of the UKCA requirements. The assessment procedure is determined based on the device’s intended use, risk class and characteristics, and depending on the manufacturer’s choice to set up a full, product or production based quality assurance system.
Once the required assessment procedure has been determined, the manufacturer meets the corresponding requirements and ensures that proof of conformity is available. This should include the appointment of a UK responsible person (UKRP) if the manufacturer is not located in the UK.
Though some class I or class A devices may be self-certified by the manufacturer, other device classes require an Approved Body to assess the evidence implemented by the company for the applied conformity assessment procedure.
Depending on the results of the conformity assessment, a certificate is issued. A certificate is required before putting the relevant medical device(s) on the market.
After the certification is issued and before its renewal, LNE-GMED UK conducts surveillance and control activities, following a process similar to that described above. These services are conducted taking into account the manufacturer’s strategy to market its medical devices, any changes made to its devices or its quality management system, the results of services previously performed, but also in consideration of any changes in regulations or standards.
As required by the Medical Device Regulations 2002, the manufacturer shall establish and keep updated technical documentation that must demonstrate conformity of the device with regulatory safety and performance requirements.
The technical documentation must cover all of the product’s life cycle, from the device’s design to its disposal, and include proof of conformity for each applicable regulatory provision.
This documentation remains available to authorities and to LNE-GMED UK in the framework of conformity assessment applications.
The purpose of establishing technical documentation, then, is to clearly present the device, its characteristics and its expected performance, so that organizations independent from the company can easily and fully understand the evidence of conformity. Evidence (validations, test reports and other documents) is an integral part of technical documentation.
In accordance with regulatory requirements, the manufacturer must establish a UKCA declaration of conformity for its device before placing it on the market or putting it into service.
The declaration of conformity is a document issued by the manufacturer, under its sole responsibility, attesting that its product fulfils the provisions of the applicable regulation and any other applicable regulations.
Once all the conditions laid out above have been met and the Approved Body has issued a UKCA marking certificate, the manufacturer can affix the UKCA marking to the device in question, which allows the manufacturer to place it on the market or put it into service.
LNE-GMED UK is a UK Approved Body able to provide you with combined services for various regulations for all types of medical devices